Ectopic pregnancy. Ectopic pregnancy, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Satisfaction with participating in the study Confirmation of ectopic pregnancy by ultrasound and ßHCG Stable hemodynamic status the gestational sac with the largest diameter of, 4 cm; Existence of low free fluid in the abdominal and pelvic cavity based on ultrasound.
Exclusion criteria
Exclusion criteria: The presence of active hepatitis The presence of kidney disease Use of immunosuppressive drugs History of severe allergy to methotrexate Leukopenia in patient CBC tests Hematopoiesis disorder
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum ßHCG level. Timepoint: On days 1, 3, 5 and 7 after injection of methotrexate. Method of measurement: blood test.;Outcome of treatment. Timepoint: 6 weeks after starting treatment. Method of measurement: The outcome of treatment is assessed as follows: The success of single-dose treatment means a 5% reduction in serum hCG levels after one week of treatment and a serum level of less than 5 mIU / mL after 6 weeks of treatment. In the multi-dose regimen, a 15% decrease in hCG serum levels after 48 hours of treatment or after 4 therapeutic doses, or hCG serum levels less than 5 mIU / mL after 6 weeks of treatment will be regarded as success of treatment. | — |
Secondary
| Measure | Time frame |
|---|---|
| Methotrexate complications such as Hair loss, gastroenteritis, Neutropenia, Fever, and Increase in liver enzyme. Timepoint: during the treatment up to six weeks after. Method of measurement: Clinical observation and doctor's diagnosis. | — |
Countries
Iran (Islamic Republic of)
Contacts
Esfahan University of Medical Sciences